|
(P1086) |
The PDE4 inhibitor roflumilast reduces weight gain by increasing energy expenditure and leads to improved glucose metabolism |
|
|
J. Möllmann, F. Kahles, C. Lebherz, B. A. Kappel, C. Bäck, F. Tacke, C. Werner, M. Federici, N. Marx, M. Lehrke (Aachen, Homburg/Saar; Rome, IT) |
|
(P1087) |
Palmitoylethanolamide promotes an anti-inflammatory macrophage phenotype and attenuates atherosclerotic plaque formation in mice |
|
|
P. Rinne, R. Guillamat-Prats, M. Rami, L. Ring, E. Van der Vorst, S. Steffens (München) |
|
(P1088) |
Toll-like receptor 2 stimulation improves peripheral blood flow recovery following experimental hindlimb ischemia injury |
|
|
K. Grote, K. Troidl, J. Schütt, R. Oberoi, A.-K. Koch, C. Winterbauer, T. Schmitz-Rixen, B. Schieffer (Marburg, Bad Nauheim, Frankfurt) |
|
(P1089) |
Intermittent NO application reduced infarct size in a model for repetitive left coronary artery occlusion in rats |
|
|
P. Hillmeister, N. Gatzke, M. Gorath, E. Buschmann, O. Ritter, I. Buschmann (Brandenburg, Hohenlockstedt) |
|
(P1090) |
Induction of remote flow velocity stimuli promotes collateral growth in a NOS-dependent manner after femoral artery occlusion |
|
|
D. Schuler, M. Cortese-Krott, M. Kelm, R. Sansone (Düsseldorf) |
|
(P1091) |
Sitagliptin-vermittelte, akzelerierte Enothelregeneration im GLP1R-knock out Mausmodell |
|
|
F.-C. Remm, D. Lener, S. Sopper, W.-M. Franz, C. Brenner (Innsbruck, AT) |